XCath Overview

  • Founded
  • 2016
  • Status
  • Private
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $5.33M
Latest Deal Amount
  • Investors
  • 1

XCath General Information


Operator of a medical device company intended to design and develop microsurgical robotic devices. The company offers steerable robotic guidewires that ensure sophisticated percutaneous endovascular intervention, enabling clinicians to get minimally invasive devices to treat life-threatening conditions such as cerebral stroke and ischemic cardiac disease.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Primary Office
  • 327 Terrace Drive
  • Houston, TX 77007
  • United States
+1 (832) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

XCath Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 08-Mar-2017 $5.33M 00.000 000.00 Completed Startup
To view XCath’s complete valuation and funding history, request access »

XCath Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000,000 00.000000 00.0 00.0 00 00.0 00.00
To view XCath’s complete cap table history, request access »

XCath Executive Team (2)

Name Title Board Seat Contact Info
Cary Vance President & Chief Executive Officer
You’re viewing 1 of 2 executive team members. Get the full list »

XCath Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
CE-Ventures Venture Capital Minority 000 0000 000000 0
To view XCath’s complete investors history, request access »